查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067484

美國動脈外科止血密封劑市場規模、佔有率和趨勢分析報告：按產品、最終用途、應用、疾病適應症和細分市場預測（2026-2033 年）

U.S. Hemostatic Sealants in Arterial Surgery Market Size, Share & Trends Analysis Report By Product, By End Use, By Application, By Disease Indication, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

美國動脈外科止血密封劑市場概述

據估計，2025 年美國動脈手術用止血密封劑市場價值為 9,550 萬美元，預計到 2033 年將達到 1.146 億美元，2026 年至 2033 年的複合年成長率為 2.3%。

市場成長主要受周邊動脈疾病(PAD)、主動脈瘤和其他需要手術介入的血管疾病負擔日益加重的驅動。

根據美國疾病管制與預防中心（CDC）統計，約有850萬美國人患有周邊動脈疾病（PAD），這種疾病在老年人和患有與糖尿病、高血壓、肥胖和吸煙相關的心血管疾病的人群中尤為常見。動脈繞道手術、動脈瘤修復術、頸動脈內膜剝離術和其他複雜血管切除術數量的不斷增加，推動了對先進止血密封劑的需求日益成長，這些密封劑能夠減少術中出血、提高手術效率並降低術後併發症的風險。

此外，微創手術和血管內治療的日益普及，以及生物可吸收和合成止血劑技術的不斷進步，也推動了市場擴張。政府和醫療機構也優先考慮提高心血管護理品質和手術效果，鼓勵醫院和手術中心採用先進的出血管理方案。這些因素共同促成了止血劑在美國動脈手術中應用的增加。

在北美，美國是動脈外科止血密封劑最主要、表現最佳的國內市場。全球血管手術數量最多、心血管疾病患者群體迅速老化、醫院基礎設施完善，以及美國食品藥物管理局（FDA）有利的法規環境，共同造就了美國作為動脈外科止血密封劑生產商最重要的市場。四大主要適應症——主動脈瘤、周邊動脈疾病以及其他急性疾病（包括主動脈夾層和創傷性動脈損傷）——各自產生基於明確定義的CPT編碼的手術需求，這直接推動了止血密封劑的使用。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國動脈外科止血密封劑市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 美國動脈外科止血密封劑市場分析工具

第4章：美國動脈外科止血密封劑市場：產品特定估算與趨勢分析

  • 美國動脈外科止血密封劑市場：基於產品的波動分析
  • 美國動脈外科止血密封劑市場：依產品分類，展望
  • 2021年至2033年市場規模、預測與趨勢分析（涵蓋以下）：
  • 纖維蛋白基密封劑
    • 合成/聚合物密封劑
    • 止血劑/密封劑組合產品

第5章：美國動脈外科止血密封劑市場：按應用分類的估算與趨勢分析

  • 美國動脈外科止血密封劑市場：基於應用的波動分析
  • 美國動脈外科止血密封劑市場：按應用領域分類，展望
  • 2021年至2033年市場規模、預測與趨勢分析（涵蓋以下）：
  • 動脈手術，包括移植血管置換術（人工血管置換術）
  • 無需使用移植物即可進行動脈修復和重組

第6章：美國動脈外科止血密封劑市場：依疾病適應症分類的估算與趨勢分析

  • 美國動脈外科止血密封劑市場：依疾病適應症分類的波動分析
  • 美國動脈外科止血密封劑市場：依疾病適應症分類，展望
  • 2021年至2033年市場規模、預測與趨勢分析（涵蓋以下）：
  • 主動脈瘤
  • 周邊動脈疾病
  • 頸動脈疾病
  • 其他

第7章：美國動脈外科止血密封劑市場：依最終用途分類的估算與趨勢分析

  • 美國動脈外科止血密封劑市場：基於最終用途的波動分析
  • 美國動脈外科止血密封劑市場：依最終用途分類，展望
  • 2021年至2033年市場規模、預測與趨勢分析（針對以下產業）
  • 公立醫院
  • 私立醫院

第8章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • Ethicon
    • Baxter International
    • Corza Medical
    • Integra LifeSciences Corporation
    • Artivion
    • Becton, Dickinson and Company（BD）
    • Teleflex
Product Code: GVR-4-68040-923-0

U.S. Hemostatic Sealants in Arterial Surgery Market Summary

The U.S. hemostatic sealants in arterial surgery market size was estimated at USD 95.5 million in 2025 and is projected to reach USD 114.6 million by 2033, growing at a CAGR of 2.3% from 2026 to 2033. Market growth is primarily driven by the increasing burden of peripheral artery disease (PAD), aortic aneurysms, and other vascular disorders requiring surgical intervention.

According to the CDC, nearly 8.5 million Americans are affected by PAD, with the disease being particularly prevalent among the aging population and patients with diabetes, hypertension, obesity, and smoking-related cardiovascular conditions. The growing volume of arterial bypass procedures, aneurysm repairs, carotid endarterectomies, and other complex vascular surgeries is increasing the demand for advanced hemostatic sealants that can reduce intraoperative bleeding, improve surgical efficiency, and lower the risk of postoperative complications.

In addition, the rising adoption of minimally invasive and endovascular procedures, along with continuous technological advancements in bioresorbable and synthetic sealant products, is further supporting market expansion. Government initiatives and healthcare organizations are also emphasizing improved cardiovascular care and surgical outcomes, encouraging hospitals and surgical centers to adopt advanced bleeding management solutions. Together, these factors are contributing to the increasing utilization of hemostatic sealants in arterial surgery across the U.S.

The U.S. is the most dominant and most procedure-intensive national market for hemostatic sealants in arterial surgery in North America. Its combination of the world's largest absolute vascular surgery caseload, a rapidly aging cardiovascular patient population, a well-resourced hospital infrastructure, and a favorable FDA regulatory environment makes it the single most important geography for hemostatic sealant manufacturers operating in the arterial surgery segment. The four key disease indications, namely, aortic aneurysms, peripheral artery disease, carotid artery disease, and other acute conditions, including aortic dissection and traumatic arterial injury, each generate a distinct and well-defined CPT-coded procedural demand base that directly drives hemostatic sealant utilization.

U.S. Hemostatic Sealants in Arterial Surgery Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. hemostatic sealants in arterial surgery market report based on product, application, disease indication, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Fibrin-based Sealants
  • Synthetic/Polymer-based Sealants
  • Combination Hemostats & Sealants
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Arterial Surgery with Graft Replacement (Artificial Vessel Replacement)
    • 35556, 35566
    • 35656, 35661, 35666
    • 35081, 35082, 35091, 35092, 35102, 35103
    • 33858, 33859, 33863, 33864, 33871, 33875, 33877
  • Arterial Repair/Reconstruction without Graft
    • 35301
    • 35371
    • 35206
    • 35286
    • 35226, 35256
  • Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)
    • Aortic Aneurysms
    • Peripheral Artery Disease
    • Carotid Artery Disease
    • Others
    • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Public Hospitals
    • Private Hospitals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Disease Indication
    • 1.2.4. End-use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Disease Indication outlook
    • 2.2.4. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Hemostatic Sealants in Arterial Surgery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing clinical evidence supporting sealant effectiveness in vascular surgery
      • 3.2.1.2. Advancements in synthetic and bioactive hemostatic technologies
      • 3.2.1.3. Favorable insurance coverage and reimbursement
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced hemostatic sealants
      • 3.2.2.2. Risk of product-related complications
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Increasing adoption of minimally invasive arterial surgeries
      • 3.2.3.2. Development of next-
  • 3.3. U.S. Hemostatic Sealants in Arterial Surgery Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. U.S. Hemostatic Sealants in Arterial Surgery Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Hemostatic Sealants in Arterial Surgery Market: Product Movement Analysis
  • 4.3. U.S. Hemostatic Sealants in Arterial Surgery Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 4.5. Fibrin-based Sealants
    • 4.5.1. Fibrin-based Sealants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Synthetic/Polymer-based Sealants
      • 4.5.2.1. Synthetic/Polymer-based Sealants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Combination Hemostats & Sealants
      • 4.5.3.1. Combination Hemostats & Sealants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Hemostatic Sealants in Arterial Surgery Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Hemostatic Sealants in Arterial Surgery Market: Application Movement Analysis
  • 5.3. U.S. Hemostatic Sealants in Arterial Surgery Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 5.5. Arterial Surgery with Graft Replacement (Artificial Vessel Replacement)
    • 5.5.1. Arterial Surgery with Graft Replacement (Artificial Vessel Replacement) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.1. 35556, 35566
        • 5.5.1.1.1. 35556, 35566 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.2. 35656, 35661, 35666
        • 5.5.1.2.1. 35656, 35661, 35666 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.3. 35081, 35082, 35091, 35092, 35102, 35103
        • 5.5.1.3.1. 35081, 35082, 35091, 35092, 35102, 35103 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.4. 33858, 33859, 33863, 33864, 33871, 33875, 33877
        • 5.5.1.4.1. 33858, 33859, 33863, 33864, 33871, 33875, 33877 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Arterial Repair/Reconstruction without Graft
    • 5.6.1. Arterial Repair/Reconstruction without Graft Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.6.1.1. 35301
        • 5.6.1.1.1. 35301 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.6.1.2. 35371
        • 5.6.1.2.1. 35371 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.6.1.3. 35206
        • 5.6.1.3.1. 35206 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.6.1.4. 35286
        • 5.6.1.4.1. 35286 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.6.1.5. 35226, 35256
        • 5.6.1.5.1. 35226, 35256 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Hemostatic Sealants in Arterial Surgery Market: Disease Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Hemostatic Sealants in Arterial Surgery Market: Disease Indication Movement Analysis
  • 6.3. U.S. Hemostatic Sealants in Arterial Surgery Market by Disease Indication Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 6.5. Aortic Aneurysms
    • 6.5.1. Aortic Aneurysms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Peripheral Artery Disease
    • 6.6.1. Peripheral Artery Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Carotid Artery Disease
    • 6.7.1. Carotid Artery Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Hemostatic Sealants in Arterial Surgery Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Hemostatic Sealants in Arterial Surgery Market: End Use Movement Analysis
  • 7.3. U.S. Hemostatic Sealants in Arterial Surgery Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 7.5. Public Hospitals
    • 7.5.1. Public Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Private Hospitals
    • 7.6.1. Private Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Ethicon
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Baxter International
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Corza Medical
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Integra LifeSciences Corporation
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Artivion
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Becton, Dickinson and Company (BD)
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Teleflex
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. hemostatic sealants in arterial surgery market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. hemostatic sealants in arterial surgery market, by application, 2021 - 2033 (USD Million)
  • Table 5 U.S. hemostatic sealants in arterial surgery market, by disease indication, 2021 - 2033 (USD Million)
  • Table 6 U.S. hemostatic sealants in arterial surgery market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. Hemostatic sealants in arterial surgery: market outlook
  • Fig. 9 U.S. Hemostatic sealants in arterial surgery market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 U.S. Hemostatic sealants in arterial surgery market driver impact
  • Fig. 15 U.S. Hemostatic sealants in arterial surgery market restraint impact
  • Fig. 16 U.S. Hemostatic sealants in arterial surgery market strategic initiatives analysis
  • Fig. 17 U.S. Hemostatic sealants in arterial surgery market: Product movement analysis
  • Fig. 18 U.S. Hemostatic sealants in arterial surgery market: Product outlook and key takeaways
  • Fig. 19 Fibrin-based sealants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Synthetic/polymer-based sealants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Combination hemostats & sealants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Hemostatic sealants in arterial surgery market: Application outlook key takeaways (USD Million)
  • Fig. 23 U.S. Hemostatic sealants in arterial surgery market: Application movement analysis (USD Million), 2024 & 2033
  • Fig. 24 Arterial surgery with graft replacement (Artificial vessel replacement) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 35556, 35566 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 35656, 35661, 35666 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 35081, 35082, 35091, 35092, 35102, 35103 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 33858, 33859, 33863, 33864, 33871, 33875, 33877 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Arterial repair/reconstruction without graft market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 35301 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 35371 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 35206 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 35286 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 35226, 35256 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Hemostatic sealants in arterial surgery market, disease indication outlook key takeaways (USD Million)
  • Fig. 36 U.S. Hemostatic sealants in arterial surgery market disease indication movement analysis (USD Million), 2024 & 2033
  • Fig. 37 Aortic aneurysms market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Peripheral artery disease market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Carotid artery disease market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Hemostatic sealants in arterial surgery market: End use outlook key takeaways (USD Million)
  • Fig. 42 U.S. Hemostatic sealants in arterial surgery market: End use movement analysis (USD Million), 2024 & 2033
  • Fig. 43 Public hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Private hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Participant categorization- U.S. Hemostatic sealants in arterial surgery market
  • Fig. 46 Market share of key market players- U.S. Hemostatic sealants in arterial surgery market